$RLFTF (opinion) by DanG on Yh0 - Things to Know a
Post# of 653
(Total Views: 361)
Posted On: 06/03/2021 8:45:27 PM
$RLFTF (opinion) by DanG on Yh0 - Things to Know as an Investor
1. The FDA and their reps are forbidden to comment on a product currently under consideration for an EUA.
2. Operation Warp Speed, the NIH, and the FDA have all been actively involved in the trials to determine in Aviptadil is an effective treatment for Covid-19. Far from being ignored, it is in the forefront.
3. It all comes down to weather or not Avipadil works in the treatment of Covid-19 and other respiratory diseases. So far it looks like it does but science takes time.
4. The present stock price is meaningless. It reflects a lack of concrete news that would increase earnings. When that comes the stock price will increase accordingly.
5. No major investor has sold this stock. Follow the money.
6. Be proud that you are invested in a company that can do enormous good in the world.
I have almost 700,000 shares and my family almost 2 million. We have not sold a single share.
1. The FDA and their reps are forbidden to comment on a product currently under consideration for an EUA.
2. Operation Warp Speed, the NIH, and the FDA have all been actively involved in the trials to determine in Aviptadil is an effective treatment for Covid-19. Far from being ignored, it is in the forefront.
3. It all comes down to weather or not Avipadil works in the treatment of Covid-19 and other respiratory diseases. So far it looks like it does but science takes time.
4. The present stock price is meaningless. It reflects a lack of concrete news that would increase earnings. When that comes the stock price will increase accordingly.
5. No major investor has sold this stock. Follow the money.
6. Be proud that you are invested in a company that can do enormous good in the world.
I have almost 700,000 shares and my family almost 2 million. We have not sold a single share.
(0)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ
Scroll down for more posts ▼